Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

MYOMO, INC. (MYO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics Q2 revenue of $6.0 million, including license revenue Nearly 1,000 prospective MyoPro® candidates with known payers in the patient pipeline Begins to build Medicare Part B patient pipeline following publication of proposed rule by the Centers for Medicare and Medicaid Services Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2023. Financial and operational highlights for the second quarter of 2023 include the following : &#x20..."
05/10/2023 8-K Quarterly results
Docs: "Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022 Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2023. Financial and operational highlights for the first quarter of 2023 include the following: • Product revenue was $3.4 million, up 20% compared with the prior year quarter..."
03/13/2023 8-K Quarterly results
Docs: "Myomo Reports Fourth Quarter and Full Year 2022 Financial Results Fourth quarter revenue was $4.0 million, up 2% sequentially 387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021 Conference call begins at 10:00 a.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and full year ended December, 31, 2022. Financial and operational highlights for the fourth quarter of 2022 include the following: • Product and total revenues were $4.0 million, up 2% sequentially and similar to the prior year quarter; • Revenue units were 101, up 16% sequentially and down 6% co..."
11/10/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions Second quarter revenue of $3.7 million up 18% over prior year Cost per pipeline addition cut in half over the last six months Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2022. Financial and operational highlights for the second quarter of 2022 include the following: • Product revenue was $3.7 million, up 18% from Q2 2021 and up 28% sequentially; • A record 420 new candidates were added to the patient pipeline, up 52% from Q2..."
05/11/2022 8-K Quarterly results
03/09/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Myomo Third Quarter 2021 Financial Results Feature Record Revenue"
08/09/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 9, 2021 Myomo, Inc. Delaware 001-38109 47-0944526 137 Portland St., 4th Floor Boston, MA 02114 Company's telephone number, including area code: 996-9058 Not applicable",
"Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders"
05/05/2021 8-K Quarterly results
11/10/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 10, 2020 Myomo, Inc. Delaware 001-38109 47-0944526 One Broadway, 14th Floor Cambridge, MA 02142 Company's telephone number, including area code: 996-9058 Not applicable",
"Myomo Third Quarter Financial Results Feature Record Revenue of $1.9 Million, up 218% Over the Prior Year"
08/11/2020 8-K Quarterly results
05/14/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/08/2019 8-K Quarterly results
Docs: "Not applicable",
"Myomo Reports Second Quarter 2019 Results"
05/13/2019 8-K Quarterly results
Docs: "Not applicable",
"Myomo Reports First Quarter 2019 Results"
03/07/2019 8-K Quarterly results
Docs: "Not applicable",
"Myomo Reports Fourth Quarter and Year End 2018 Financial Results"
11/05/2018 8-K Quarterly results
Docs: "Not applicable",
"Myomo Announces Third Quarter 2018 Financial Results"
08/07/2018 8-K Quarterly results
Docs: "FORM 8-K",
"Myomo Announces Second Quarter 2018 Financial Results"
05/09/2018 8-K Quarterly results
Docs: "Not applicable",
"Myomo Reports First Quarter 2018 Results CAMBRIDGE, Mass., May 9, 2018 - Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the first quarter ended March 31, 2018. Recent Highlights and Accomplishments:"
11/06/2017 8-K Quarterly results
Docs: "Myomo, Inc. Reports Third Quarter 2017 Results"
08/14/2017 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy